Computed tomographic features of peritoneal carcinomatosis treated by intraperitoneal chemohyperthermia

Journal of Computer Assisted Tomography

Volumn 27, Issue 3, 2003, Pages 327-332

  Dromain, Clarisse ^a   Bisdorff, Annouk ^b   Elias, Dominique ^b   Antoun, Sami ^b   Boige, Valerie ^b   Lasser, Philippe ^b   Sigal, Robert ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b NONE

Author keywords

Abdomen neoplasm, abdomen CT; CT; Peritoneum; Peritoneum neoplasm

Indexed keywords

COMPUTERIZED TOMOGRAPHY; TUMORS;

ABDOMEN - NEOPLASM, ABDOMEN - COMPUTED TOMOGRAPHY; COMPUTED TOMOGRAPHIC; COMPUTED TOMOGRAPHY; COMPUTED TOMOGRAPHY SCAN; CONTRAST-ENHANCED; INTRAPERITONEAL; MEAN AGES; PERITONEAL CARCINOMATOSIS; PERITONEUM; PERITONEUM - NEOPLASM;

SURGERY;

ANTINEOPLASTIC AGENT; IOBITRIDOL; NONIONIC CONTRAST MEDIUM; OXALIPLATIN;

ABDOMINAL ABSCESS; ACUTE PANCREATITIS; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CARCINOMATOUS PERITONITIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; HEMOPERITONEUM; HUMAN; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MALE; PERITONEUM; PERITONEUM CANCER; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; URINARY TRACT FISTULA;

EID: 0038755217     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-200305000-00005     Document Type: Article

References (23)

1. Chu DZ, Lang NP, Thompson C, et al. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989;63:364-7.
2. Witkamp AJ, de Bree E, Kaag MM, et al. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 2001;88:458-63.
3. Elias D, Detroz B, Debaene B, et al. Treatment of peritoneal carcinomatosis by intraperitoneal chemohyperthermia: reliable and unreliable concepts. Hepatogastroenterology 1994;41:207-13.
4. Yonemura Y, Fujimura T, Nishimura G, et al. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 1996;119:437-44.
5. Beaujard AC, Glehen O, Caillot JL, et al. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 2000;88:2512-9.
6. Galen WP. Hyperthermia and chemotherapy. Adv Exp Med Biol 1990;267:209-16.
7. Elias D, Blot F, El Otmany A, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001;92:71-6.
8. Antoun S, Meshaka P, Soltani D, et al. Complications and tolerance of heated intraperitoneal chemotherapy and cytoreductive surgery for peritoneal carcinomatosis: results of a phase I-II study of peritoneal carcinomatosis from different sources. Bull Cancer 2000;87:665-70.
9. Jacquet P, Stephens AD, Averbach AM, et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 1996;77:2622-9.
10. Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999;6:790-6.
11. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995;221:124-32.
12. Elias D, Gachot B, Bonvallot S, et al. Peritoneal carcinosis treated by complete excision and immediate postoperative intraperitoneal chemotherapy. Phase II study in 54 patients. Gastroenterol Clin Biol 1997;21:181-7.
13. Lyerly HK. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis. Ann Surg 1995;221:123.
14. Begossi G, Gonzalez-Moreno S, Ortega-Perez G, et al. Cytoreduc-tion and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma. Eur J Surg Oncol 2002;28:80-7.
15. Los G, Sminia P, Wondergem J, et al. Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in rats. Eur J Cancer 1991;27:472-7.
16. Hahn GM. Potential for therapy of drugs and hyperthermia. Cancer Res 1979;39:2264-8.
17. Song CW. Effect of local hyperthermia on blood flow and microenvironment: a review. Cancer Res 1984;44:4721s-30s.
18. Shimizu T, Maeta M, Koga S. Influence of local hyperthermia on the healing of small intestinal anastomoses in the rat. Br J Surg 1991;78:57-9.
19. Macari M, Balthazar EJ. CT of bowel wall thickening: significance and pitfalls of interpretation. AJR Am J Roentgenol 2001;176:1105-16.
20. Frager DH, Goldman M, Beneventano TC. Computed tomography in Crohn disease. J Comput Assist Tomogr 1983;7:819-24.
21. Jones B, Fishman EK, Hamilton SR, et al. Submucosal accumulatin of fat in inflammatory bowel disease: CT/pathologic correlation. J Comput Assist Tomogr 1986;10:759-63.
22. Meyers MA, McGuire PV. Spiral CT demonstration of hypervascularity in Crohn disease: "vascular jejunization of the ileum" or the "comb sign." Abdom Imaging 1995;20:327-32.
23. van der Kolk BM, de Man BM, Wobbes T, et al. Is early postoperative treatment with 5-fluorouracil possible without affecting anastomotic strength in the intestine? Br J Cancer 1999;79:545-50.